To assess the value of these findings, we next analyzed the expression of perforin and GzmB in M-MDSCs (CD11b+CD33+CD14+HLA-DRlow) and PMN-MDSCs (CD11b+CD33+CD15+) of colon cancer patients and healthy donors. This evidence concerns the gene CD33 and malignant colon neoplasm.